ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 149 filers reported holding ASCENDIS PHARMA A/S in Q1 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $351,000 | +33.0% | 2,993 | +52.5% | 0.02% | +36.4% |
| Q4 2021 | $264,000 | -41.2% | 1,963 | -30.4% | 0.01% | -50.0% |
| Q3 2021 | $449,000 | +44.4% | 2,819 | +19.1% | 0.02% | +37.5% |
| Q2 2021 | $311,000 | +5.8% | 2,367 | +3.7% | 0.02% | -5.9% |
| Q1 2021 | $294,000 | -7.5% | 2,282 | +19.9% | 0.02% | -22.7% |
| Q4 2020 | $318,000 | -17.6% | 1,904 | -23.9% | 0.02% | -85.1% |
| Q3 2020 | $386,000 | +0.8% | 2,503 | -3.4% | 0.15% | +335.3% |
| Q2 2020 | $383,000 | +23.5% | 2,590 | -6.0% | 0.03% | +3.0% |
| Q1 2020 | $310,000 | -32.2% | 2,755 | -16.1% | 0.03% | -5.7% |
| Q4 2019 | $457,000 | – | 3,282 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,046,832 | $240,912,000 | 24.02% |
| RA Capital Management | 4,132,442 | $486,388,000 | 20.97% |
| VHCP Management II, LLC | 504,210 | $59,346,000 | 17.36% |
| Ghost Tree Capital, LLC | 385,000 | $45,315,000 | 11.84% |
| Sofinnova Investments, Inc. | 998,538 | $117,528,000 | 11.33% |
| Foresite Capital Management IV, LLC | 245,424 | $28,886,000 | 10.38% |
| Avoro Capital Advisors LLC | 1,795,000 | $211,272,000 | 9.14% |
| Orbimed Advisors | 3,970,673 | $467,348,000 | 7.24% |
| Eventide Asset Management | 1,698,648 | $199,931,000 | 6.88% |
| Foresite Capital Management III, LLC | 204,088 | $24,021,000 | 6.25% |